EP 1643973 A1 20060412 - PHARMACEUTICAL FORMULATIONS COMPRISING MAGNESIUM STEARATE
Title (en)
PHARMACEUTICAL FORMULATIONS COMPRISING MAGNESIUM STEARATE
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNGEN ENTHALTEND MAGNESIUMSTEARAT
Title (fr)
PREPARATIONS PHARMACEUTIQUES CONTENANT DU STEARATE DE MAGNESIUM
Publication
Application
Priority
- EP 2004007666 W 20040708
- GB 0316341 A 20030711
- US 50541503 P 20030923
Abstract (en)
[origin: WO2005004845A1] The invention relates to the use of magnesium stearate to inhibit or reduce chemical interaction between an active ingredient substance and a carrier in a solid pharmaceutical formulation, wherein the active ingredient substance is susceptible to chemical interaction with the carrier. An inhalable solid pharmaceutical formulation comprising (a) an active ingredient substance susceptible to chemical interaction with lactose, (b) a carrier and (c) magnesium stearate is also provided together with uses thereof and methods related thereto.
IPC 1-7
IPC 8 full level
CPC (source: EP)
A61K 9/0075 (2013.01); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 11/08 (2017.12); A61P 27/16 (2017.12)
Citation (search report)
See references of WO 2005004845A1
Citation (examination)
WO 8705213 A1 19870911 - CHIESI FARMA SPA [IT]
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2005004845 A1 20050120; EP 1643973 A1 20060412; JP 2009513529 A 20090402
DOCDB simple family (application)
EP 2004007666 W 20040708; EP 04740921 A 20040708; JP 2006518169 A 20040708